找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Essential Pharmaceutics; Ashlee D. Brunaugh,Hugh D. C. Smyth,Robert O. Will Textbook 2019 American Association of Pharmaceutical Scientist

[復(fù)制鏈接]
樓主: 方面
31#
發(fā)表于 2025-3-27 00:03:26 | 只看該作者
https://doi.org/10.1007/0-387-28273-4e discussed, including particle settling, flocculation, particle aggregation, viscosity, zeta potential, and Ostwald ripening are discussed. Methods of particle size reduction are introduced, including those to produce nanoparticles. An extensive discussion of relevant excipients is also included.
32#
發(fā)表于 2025-3-27 02:06:58 | 只看該作者
Why Technical Solutions are Insufficientanisms for drug transport through the skin, in vitro analytical techniques, and methods to increase drug permeation. Commonly used formulation approaches such as semisolid dosage forms and transdermal patches are also discussed.
33#
發(fā)表于 2025-3-27 08:15:41 | 只看該作者
https://doi.org/10.1007/978-94-011-4321-9, as are the mechanisms for overcoming these barriers through delivery device and formulation design. A review is provided of delivery mechanisms and design of the three major classes of pulmonary drug delivery devices (pressurized metered dose inhalers, nebulizers, and dry powder inhalers). For eac
34#
發(fā)表于 2025-3-27 12:17:47 | 只看該作者
35#
發(fā)表于 2025-3-27 16:48:32 | 只看該作者
AAPS Introductions in the Pharmaceutical Scienceshttp://image.papertrans.cn/e/image/315504.jpg
36#
發(fā)表于 2025-3-27 17:48:21 | 只看該作者
37#
發(fā)表于 2025-3-27 23:15:49 | 只看該作者
38#
發(fā)表于 2025-3-28 02:51:19 | 只看該作者
Capsule and Tablet Dosage Forms,egories are provided along with general functions and examples. A review of USP-recommended analytical tests is also included. Lastly, this chapter introduces techniques for formulating poorly water soluble drugs in capsule and tablet dosage forms.
39#
發(fā)表于 2025-3-28 09:46:44 | 只看該作者
Pulmonary Drug Delivery,design of the three major classes of pulmonary drug delivery devices (pressurized metered dose inhalers, nebulizers, and dry powder inhalers). For each class of device, appropriate formulation approaches are discussed.
40#
發(fā)表于 2025-3-28 13:05:30 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-20 18:36
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
金溪县| 上犹县| 微山县| 五莲县| 陇南市| 阳泉市| 上林县| 克山县| 永春县| 梧州市| 红安县| 北川| 开原市| 台江县| 滁州市| 遂溪县| 洪洞县| 临猗县| 青田县| 郎溪县| 常州市| 郎溪县| 平塘县| 崇阳县| 营山县| 册亨县| 汉沽区| 岐山县| 海原县| 南江县| 西安市| 五家渠市| 赣州市| 信宜市| 松江区| 本溪| 台南市| 淮南市| 开远市| 杭州市| 鄂尔多斯市|